Invention relates to an extended release formulation of a broad spectrum macrolide antibiotic such as clarithromycin comprising a unique blend of polymer matrix using two different grades hydroxypropylmethyl cellulose, sodium carbonate and other excepients in an optimized ratio to achieve…
Invention relates to a whey treatment in dairy industry collecting the whey as wastewater from cheese and/or paneer production section, performing chemical pre-treatment step using a combinations of chemical coagulants and adsorbents, passing through an integrated membrane cassette for whey…
Invention relates to Ethosome compositions for transdermal drug delivery comprises therapeutically effective amount of curcumin, phospholipon 90H, cholesterol, propylene glycol and ethanol. The process comprises dissolving curcumin, cholesterol and phospholipon 90H in ethanol and propylene, addition of distilled water, cooling…
Invention relates to a process for detecting the presence or absence of human hemoglobin HbAO and/or HbE in a sample by way of nanoparticle -hemoglobin interaction. Process for detecting the presence or absence of human hemoglobin HbAO and/or HbE in…
Invention relates to a process for preparation of nanocrystals of poorly water soluble drugs to increase the solubility and dissolution rate and bioavailability. It is an improved process for preparation of nanocrystals of lovastatin (LVS) to increase the solubility and…
Technology relates to an inexpensive and extremely effective synthetic lung surfactant, which has the potential to save the lives of babies, children and adults suffering with any of a range of respiratory and lung ailments. Synthetic formulation consisting of a…
Invention relates to the field of novel anticancer agents. Compounds shown in figure are useful for the treatment of cancer, AIDS, HIV infections and asthma. Patent Application Number: 7332629 For more details about technology: Click Here
Technology relates to a Chemoenzymatic process for the stereoselective preparation of both (R) and (S) enantiomers of 3-hydroxy-3-phenylpropanenitrile, useful as a key intermediate for synthesis of (S)-Fluoxetine, (R)-Tomoxetine and cognant compounds. Patent Application Number: WO/2002/057475, Granted Indian and UK…
Invention relates to Polyisoprenylated benzophenones and their isomers as inhibitors of histone acetyltransferases. These compounds are useful as biological switching molecules for evaluating the role of p300 and PCAF in cellular functions and also may be useful as new chemical…
Technology relates to a Chemoenzymatic process for the stereoselective preparation of both enantiomers of 3-hydroxy-3-(2-thienyl) propanenitrile, which are optically pure intermediates for the synthesis of both enantiomers of duloxetine in high enantiomeric excess. Patent Number: 7045341, Granted Indian and…